Zeo ScientifiX (ZEOX) Accounts Payables (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Accounts Payables of $2.1 million for Q2 2026, up 13.69% year-over-year from $1.9 million in Q2 2025, and up 8.73% quarter-over-quarter from $2.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Accounts Payables (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Accounts Payables history runs 15 years deep, the most recent figure standing at $2.1 million for Q2 2026.
- In Q2 2026, Accounts Payables rose 13.69% year-over-year to $2.1 million; the TTM figure through Apr 2026 stood at $2.1 million (up 13.69% YoY), while the FY2025 annual figure was $2.0 million, up 15.18% from the prior year.
- Accounts Payables for Q2 2026 stood at $2.1 million, up from $2.0 million in the prior quarter.
- The five-year high for Accounts Payables was $2.7 million in Q2 2022, with the low at $1.7 million in Q4 2024.
- The 5-year median for Accounts Payables is $2.2 million (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables soared 66.53% in 2022, then plunged 34.19% in 2024.
- Zeo ScientifiX's Accounts Payables stood at $2.4 million in 2022, then rose by 9.82% to $2.6 million in 2023, then slumped by 34.19% to $1.7 million in 2024, then gained by 15.18% to $2.0 million in 2025, then climbed by 8.23% to $2.1 million in 2026.
- Business Quant data shows ZEOX's Accounts Payables at $2.1 million in Q2 2026, $2.0 million in Q1 2026, and $2.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.14 Mn |
| Jan 31, 2026 | 1.97 Mn |
| Oct 31, 2025 | 1.98 Mn |
| Jul 31, 2025 | 2.42 Mn |
| Apr 30, 2025 | 1.89 Mn |
| Jan 31, 2025 | 1.76 Mn |
| Oct 31, 2024 | 1.72 Mn |
| Jul 31, 2024 | 1.85 Mn |
| Apr 30, 2024 | 1.93 Mn |
| Jan 31, 2024 | 2.22 Mn |
| Oct 31, 2023 | 2.61 Mn |
| Jul 31, 2023 | 2.43 Mn |
| Apr 30, 2023 | 2.54 Mn |
| Jan 31, 2023 | 2.27 Mn |
| Oct 31, 2022 | 2.38 Mn |
| Jul 31, 2022 | 2.59 Mn |
| Apr 30, 2022 | 2.66 Mn |
| Jan 31, 2022 | 1.96 Mn |
| Oct 31, 2021 | 1.87 Mn |
| Jul 31, 2021 | 1.94 Mn |